PH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 7359-7370

  Wang, Yiwen ^a   Qin, Fei ^a   Tan, Haina ^a   Zhang, Yan ^a   Jiang, Miao ^a   Lu, Mei ^a   Yao, Xin ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cell viability; Encapsulation efficiency; Loading capacity; MCF 7; Surface plasmon resonance; SW480

Indexed keywords

CARBOXYLIC ACID; DOXORUBICIN; GLYCOL CHITOSAN CARBOXYMETHYL BETA CYCLODEXTRIN NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BETA CYCLODEXTRIN DERIVATIVE; CARBOXYMETHYL-BETA-CYCLODEXTRIN; CHITOSAN; DELAYED RELEASE FORMULATION; DRUG CARRIER; GLYCOL-CHITOSAN;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL LINE; CANCER INHIBITION; CELL VIABILITY ASSAY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DISSOCIATION; DRUG DETERMINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; MCF 7 CELL LINE; NANOENCAPSULATION; PARTICLE SIZE; PH; PH MEASUREMENT; PHYSICAL CHEMISTRY; SENSITIVITY ANALYSIS; SW480 CELL LINE; ZETA POTENTIAL; CELL PROLIFERATION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG RELEASE; MCF-7 CELL LINE;

ANTINEOPLASTIC AGENTS; BETA-CYCLODEXTRINS; CELL PROLIFERATION; CHITOSAN; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG CARRIERS; DRUG LIBERATION; HUMANS; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; NANOPARTICLES;

EID: 84949807303     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S91906     Document Type: Article

References (38)

1. Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem. 2005;13:5043-5054.
2. Gao WW, Chan JM, Farokhzad OC. pH-Responsive nanoparticles for drug delivery. Mol Pharm. 2010;7:1913-1920.
3. Li YY, Zhang XZ, Kim GC, Cheng H, Cheng SX, Zhuo RX. Thermosensitive Y-shaped micelles of poly(oleic acid-Y-N-isopropylacrylamide) for drug delivery. Small. 2006;2:917-923.
4. Meng L, Huang W, Wang D, Huang X, Zhu X, Yan D. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery. Biomacromolecules. 2013;14:2601-2610.
5. Chen W, Cheng Y, Wang B. Dual-responsive boronate crosslinked micelles for targeted drug delivery. Angew Chem Int Ed Engl. 2012;51:5293-5295.
6. Li Y, Xiao W, Xiao K, et al. Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angew Chem Int Ed Engl. 2012;51:2864-2869.
7. She W, Luo K, Zhang C, et al. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy. Biomaterials. 2013;34:1613-1623.
8. Thomas MB, Radhakrishnan K, Gnanadhas DP, Chakravortty D, Raichur AM. Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules. Int J Nanomedicine. 2013;8:267-273.
9. Sampathkumar K, Arulkumar S, Ramalingam M. Advances in stimuli responsive nanobiomaterials for cancer therapy. J Biomed Nanotechnol. 2014;10:367-382.
10. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 2010;62:59-82.
11. Hyung Park J, Kwon S, Lee M, et al. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials. 2006;27:119-126.
12. Kim JH, Kim YS, Park K, et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials. 2008;29:1920-1930.
13. Nogueira DR, Tavano L, Mitjans M, Pérez L, Infante MR, Vinardell MP. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials. 2013;34:2758-2772.
14. Alamdarnejad G, Sharif A, Taranejoo S, et al. Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole. J Mater Sci Mater Med. 2013;24:1939-1949.
15. Min KH, Park K, Kim YS, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release. 2008;127:208-218.
16. Janes KA, Fresneau MP, Marazuela A. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release. 2001;73:255-267.
17. Ji JG, Hao SL, Liu WQ, et al. Preparation and evaluation of O-carboxymethyl chitosan/cyclodextrin nanoparticles as hydrophobic drug delivery carriers. Polym Bull. 2011;67:1201-1213.
18. Park JM, Lee SY, Lee GH, et al. Design and characterisation of doxorubicin-releasing chitosan microspheres for anti-cancer chemoembolisation. J Microencapsul. 2012;29:695-705.
19. Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov. 2004;3:1023-1035.
20. Zhang XG, Wu ZM, Gao XJ, et al. Chitosan bearing pendant cyclodextrin as a carrier for controlled protein release. Carbohydr Polym. 2009;77:394-401.
21. Wang X, Chen CJ, Huo D, et al. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers. Carbohydr Polym. 2012;90:361-369.
22. Trapani A, Lopedota A, Franco M, et al. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Eur J Pharm Biopharm. 2010;75:26-32.
23. Yuan Z, Ye Y, Gao F, et al. Chitosan-graft-beta-cyclodextrin nanoparticles as a carrier for controlled drug release. Int J Pharm. 2013;446:191-198.
24. Prabaharan M, Mano JF. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug. Macromol Biosci. 2005;5:965-973.
25. Reuben J, Rao CT, Pitha J. Distribution of substituents in carboxymethyl ethers of cyclomaltoheptaose. Carbohydr Res. 1994;258:281-285.
26. Tan HN, Xue Y, Luan QF, Yao X. Evaluation of glycol chitosan-graft-carboxymethyl β-cyclodextrin as potential pH-sensitive anticancer drug carrier by surface plasmon resonance. Anal Methods. 2012;4:2784-2790.
27. Krauland A, Alonso M. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int J Pharm. 2007;340:134-142.
28. Mahmoud AA, El-Feky GS, Kamel R, Awad GE. Chitosan/sulfobutylether-beta-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm. 2011;413:229-236.
29. Sims JT, Plattner R. MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines. Cancer Chemother Pharmacol. 2009;64:629-633.
30. Tanaka F, Koga T, Kojima H, Francoise MW. Hydration and phase separation of temperature-sensitive water-soluble polymers. Chin J Polym Sci. 2010;29:13-21.
31. Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm. 2009;381:122-129.
32. Lu C, Xing MM, Zhong W. Shell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid-cleavable linkage. Nanomedicine. 2011;7:80-87.
33. Yaroslavov AA, Kuchenkova OY, Okuneva IB, et al. Effect of polylysine on transformations and permeability of negative vesicular membranes. Biochim Biophys Acta. 2003;1611:44-54.
34. Badruddoza AZ, Tay AS, Tan PY, Hidajat K, Uddin MS. Carboxymethyl-β-cyclodextrin conjugated magnetic nanoparticles as nano-adsorbents for removal of copper ions: synthesis and adsorption studies. J Hazard Mater. 2011;185:1177-1186.
35. Xu YM, Du YM. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 2003;250:215-226.
36. Bodek KH, Kufelnicki A. Protolytic and complexing properties of microcrystalline chitosan with Co(ll), Zn(ll), and Cu(ll) Ions. J Appl Polym Sci. 1995;57:645-651.
37. Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29:2893-2904.
38. Lee SJ, Min KH, Lee HJ, et al. Ketal cross-linked poly(ethylene glycol)-poly(amino acid)s copolymer micelles for efficient intracellular delivery of doxorubicin. Biomacromolecules. 2011;12:1224-1233.